Literature DB >> 7000220

The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy.

R A Miller, M W May, W F Hendry, H N Whitfield, J E Wickham.   

Abstract

This study examines the effect of antifibrinolytic therapy on the incidence of secondary haemorrhage following endoscopic surgery. One hundred consecutive patients were allocated randomly to treatment and control groups. The incidence of secondary haemorrhage was reduced from 56% in the control group to 24% in the treatment group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000220     DOI: 10.1111/j.1464-410x.1980.tb02914.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  12 in total

Review 1.  What is the evidence for using hemostatic agents in surgery?

Authors:  Brian L Erstad
Journal:  Eur Spine J       Date:  2004-05-07       Impact factor: 3.134

2.  The evaluation of transcervical prostatectomy.

Authors:  S K Saha
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

Review 3.  Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.

Authors:  Robert J Porte; Frank W G Leebeek
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 5.  Prevention and management of TURP-related hemorrhage.

Authors:  Liam E Kavanagh; Gregory S Jack; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2011-08-16       Impact factor: 14.432

6.  Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study.

Authors:  Cong Zhu; Lan Yang; Hao Zi; Bing-Hui Li; Qiao Huang; Meng-Xin Lu; Xiao-Dong Li; Xuan-Yi Ren; Hua Tao; Hankun Hu; Xian-Tao Zeng
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

Review 7.  Efficacy and Safety of Tranexamic Acid in Cancer Surgery. An Update of Clinical Findings and Ongoing Research.

Authors:  Tamara Zec; Raffaela Di Napoli; Lydwine Fievez; Mohamed Ben Aziz; Alessandro Ottaiano; Alessandro Vittori; Francesco Perri; Marco Cascella
Journal:  J Multidiscip Healthc       Date:  2022-07-05

8.  Von Willebrand disease: an overview.

Authors:  K Pavani Bharati; U Ram Prashanth
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

Review 9.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.

Authors:  Katharine Ker; Phil Edwards; Pablo Perel; Haleema Shakur; Ian Roberts
Journal:  BMJ       Date:  2012-05-17

10.  Tranexamic acid decreases blood loss during transurethral resection of the prostate (TUR -P).

Authors:  Sükrü Kumsar; Ayhan Dirim; Serdar Toksöz; Hasan S Sağlam; Oztuğ Adsan
Journal:  Cent European J Urol       Date:  2011-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.